Sarah Hein

Sarah Hein is a Cofounder & CEO at March Biosciences with experience as an Entrepreneur in Residence at TMC Innovation. Previously, Sarah served as Vice President of Operations at Courier Therapeutics and held roles at Resonant Therapeutics, Mercury Fund, Baylor College of Medicine, and University of Wyoming. Sarah holds a PhD in Molecular and Cellular Biology from Baylor College of Medicine.